IMAX 将来の成長

NYSE:IMAX - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	435	51	100	132	8
12/31/2025	416	51	89	116	11
12/31/2024	379	40	47	81	11
9/30/2024	346	23	19	63	N/A
6/30/2024	358	21	17	57	N/A
3/31/2024	367	26	-9	26	N/A
12/31/2023	375	25	26	59	N/A
9/30/2023	387	25	43	71	N/A
6/30/2023	352	4	21	48	N/A
3/31/2023	328	-7	11	42	N/A
12/31/2022	301	-23	-15	17	N/A
9/30/2022	311	-15	-4	26	N/A
6/30/2022	299	-15	-7	18	N/A
3/31/2022	276	-21	-7	13	N/A
12/31/2021	255	-22	-12	6	N/A
9/30/2021	202	-54	-25	-12	N/A
6/30/2021	183	-93	-29	-19	N/A
3/31/2021	141	-109	-50	-40	N/A
12/31/2020	137	-144	-32	-23	N/A
9/30/2020	205	-104	-28	-8	N/A
6/30/2020	254	-48	-8	21	N/A
3/31/2020	350	-11	56	97	N/A
12/31/2019	396	47	40	90	N/A
9/30/2019	380	30	47	109	N/A
6/30/2019	376	26	46	112	N/A
3/31/2019	370	23	36	94	N/A
12/31/2018	374	23	53	110	N/A
9/30/2018	391	26	41	90	N/A
6/30/2018	408	20	N/A	95	N/A
3/31/2018	397	11	N/A	101	N/A
12/31/2017	381	2	N/A	85	N/A
9/30/2017	362	6	N/A	96	N/A
6/30/2017	349	10	N/A	79	N/A
3/31/2017	353	18	N/A	72	N/A
12/31/2016	376	29	N/A	78	N/A
9/30/2016	389	42	N/A	87	N/A
6/30/2016	388	48	N/A	102	N/A
3/31/2016	404	66	N/A	83	N/A
12/31/2015	374	55	N/A	84	N/A
9/30/2015	357	53	N/A	57	N/A
6/30/2015	332	50	N/A	70	N/A
3/31/2015	305	39	N/A	79	N/A
12/31/2014	291	39	N/A	87	N/A
9/30/2014	293	46	N/A	94	N/A
6/30/2014	284	43	N/A	82	N/A
3/31/2014	286	42	N/A	70	N/A
12/31/2013	288	44	N/A	55	N/A

アナリストによる今後の成長予測

収入対貯蓄率: IMAXの予測収益成長率 (年間20.9% ) は貯蓄率 ( 2.6% ) を上回っています。

収益対市場: IMAXの収益 ( 20.9% ) はUS市場 ( 15.3% ) よりも速いペースで成長すると予測されています。

高成長収益: IMAXの収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: IMAXの収益 ( 8.6% ) US市場 ( 8.9% ) よりも低い成長が予測されています。

高い収益成長: IMAXの収益 ( 8.6% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: IMAXの自己資本利益率は、3年後には低くなると予測されています ( 16.8 %)。

IMAX 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

Consensus EPS estimates increase by 22%, revenue downgraded

Consensus EPS estimates increase by 20%

Price target increased by 8.0% to US$24.36

Consensus EPS estimates increase by 13%

IMAX Corporation Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next

IMAX Corporation Provides Revenue Guidance for the Fiscal Year 2025

Recent updates

After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar

Investor sentiment improves as stock rises 16%

Consensus EPS estimates increase by 22%, revenue downgraded

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly

IMAX Corporation to Report Q3, 2024 Results on Oct 30, 2024

If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity

IMAX Corporation Names Jonathan Fischer as Chief Content Officer

IMAX Corporation: Undervalued Relative To Revenue Growth And Margin Expansion Potential

When Should You Buy IMAX Corporation (NYSE:IMAX)?

Returns On Capital At IMAX (NYSE:IMAX) Paint A Concerning Picture

Consensus EPS estimates increase by 20%

IMAX Corporation: Upbeat Mid-Term Outlook After Great Q2 Signings

Price target increased by 8.0% to US$24.36

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Pinning Down IMAX Corporation's (NYSE:IMAX) P/S Is Difficult Right Now

IMAX Corporation to Report Q2, 2024 Results on Jul 25, 2024

Is IMAX (NYSE:IMAX) A Risky Investment?

Is It Too Late To Consider Buying IMAX Corporation (NYSE:IMAX)?

Consensus EPS estimates increase by 13%

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

IMAX Corporation to Report Q1, 2024 Results on Apr 25, 2024

IMAX Corporation: Good Reasons To Be Bullish

Chief Legal Officer & Senior EVP recently sold US$422k worth of stock

IMAX Corporation, Annual General Meeting, Jun 06, 2024

President of IMAX Theatres exercised options and sold US$357k worth of stock

IMAX Corporation Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next

IMAX Corporation Provides Revenue Guidance for the Fiscal Year 2025

Full year 2023 earnings: EPS exceeds analyst expectations

When Should You Buy IMAX Corporation (NYSE:IMAX)?

IMAX Corporation to Report Q4, 2023 Results on Feb 27, 2024

IMAX Corporation: Bull Case Has Merits, But I Am Not Interested

IMAX Corporation Appoints Anne Globe as Chief Marketing Officer

CEO & Director exercised options and sold US$1.4m worth of stock

IMAX Corporation: International Expansion Remains A Bright Spot

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Some Investors May Be Worried About IMAX's (NYSE:IMAX) Returns On Capital

IMAX Corporation to Report Q3, 2023 Results on Oct 25, 2023

IMAX Appears Expensive After Post-Pandemic Appreciation

IMAX Corporation Stock: Bullish Following A Blockbuster Summer

Should You Think About Buying IMAX Corporation (NYSE:IMAX) Now?

These Return Metrics Don't Make IMAX (NYSE:IMAX) Look Too Strong

IMAX Corporation: Coming Back To Life

Are Investors Undervaluing IMAX Corporation (NYSE:IMAX) By 31%?

CEO & Director recently sold US$2.1m worth of stock

Price target increased by 7.1% to US$23.36

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Is It Time To Consider Buying IMAX Corporation (NYSE:IMAX)?

IMAX (NYSE:IMAX) Is Carrying A Fair Bit Of Debt

President of IMAX Theatres recently sold US$367k worth of stock

Price target increased by 7.4% to US$21.09

Full year 2022 earnings released: US$0.40 loss per share (vs US$0.38 loss in FY 2021)

Price target increased by 7.0% to US$20.82

IMAX Non-GAAP EPS of $0.19 misses by $0.03, revenue of $98M beats by $1.77M

IMAX, Cinema XXI expand relationship with deal for ten new theatres in Indonesia

IMAX Corporation to Report Q4, 2022 Results on Feb 22, 2023

IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively

IMAX Corporation: All Eyes On China

IMAX plans to add seven new locations in Japanese expansion

CEO & Director exercised options and sold US$1.3m worth of stock

IMAX Corporation Names Daniel Manwaring as Chief Executive Officer

IMAX China gets new key person

IMAX Corporation Announces Executive Changes

President of IMAX Theatres exercised options and sold US$126k worth of stock

Insider recently sold US$104k worth of stock

Is IMAX (NYSE:IMAX) A Risky Investment?

Price target decreased to US$18.73

Insufficient new directors

Price target decreased to US$19.18